AntiVIRII

antiVIRII (AVIIR)

STAY AHEAD OF THE CURVE

The Worlds Best Antiviral contains standardized extracts of three of the greatest
antiviral herbs, formulated by renowned Panaxea CEO, Dr. Daniel Weber.

Dr. Daniel Weber, DSc, PhD has
created unique medicines.

He is doing research nobody
else is doing.

Long-Haul SARS-CoV2

Multiorgan system effects of COVID-19 have been documented in most, if not all, body systems, including cardiovascular, pulmonary, renal, dermatologic, neurologic, and psychiatric. Multisystem inflammatory syndrome (MIS) and autoimmune conditions can also occur after COVID-19. MIS can lead to longer term symptoms due to unresolved complications from the illness.

antiVIRII (AVIIR) for CORONAVIRUS - USA only

Disclaimer: This is not a claim for treating SARS CoV2. Panaxea Anti-Virii has shown a number of studies on the SARS CoV1, and recently on SARS CoV2. Anti-Virii has multiple anti-inflammatory properties as well as being pulmonary protective. Prof Weber developed this formulation in 2003 for treating the then SARS epidemic and very recent research, see below, reinforces literature on the isolates contained in Panaxea Anti-Virii.


Developed from research by Prof Daniel Weber and being prescribed since 2003.

ANDROGRAPHOLIDE
Andrographis paniculata extract and andrographolide have potent anti-SARS-CoV-2 activity. Andrographolide possesses drug-like properties and could be a promising drug for further biochemical and cell-based experimental validation for combating severe COVID-19.

TARAXASTEROL
Taraxacum, containing Taraxasterol has shown biological activity against COVID-19, through its antiviral and immune system effects.

CHLOROGENIC ACID
Chlorogenic acid had potential anti-SARS-CoV-2 activity via integrating three common receptors in clinical practice compared with clinical trial drugs registered for the treatment of COVID-19, as shown by molecular docking.

INGREDIENTS
Andrographis Paniculata (contains: standardized Andrographolide 95%)

 

Taraxacum Officinalis (contains: standardized Taraxasterol 20%)

 

Lonerica Japonica (contains: standardized Chlorogenic acid 25%)

Additional PANAXEA™ products with antiviral activity

Rhein

Rhein is a potential multi-target therapeutic compound for COVID-19, through its antiviral, cardioprotective effects.

Emo)din

Emodin has shown pharmacological effects in the treatment of infection with severe acute respiratory syndrome coronavirus-2, which leads to COVID-19.

PaC

Phenolic acids possess strong antiviral activities and can be considered in the development of medical treatments against the spread of COVID-19 and its related symptoms.

IM 1

Astragalus has important therapeutic applications in regulating the body’s immune system and possessing antiviral properties.

IM 3

Mushrooms possess multiple therapeutic applications that can be used in the treatment strategies for COVID-19.

Mega-EGCG

EGCG is shown to be able to bind strongly with many molecules in viruses, especially protease and protein; therefore, it influences their functional activities.